Business Standard

Eris Lifesciences gains 6% as 3% equity changes hands via block deals

Around 3.82 million equity shares, representing 2.78 per cent of total equity, of Eris Lifesciences changed hands on the BSE, the exchange data shows.

Illustration by Ajay Mohanty
Premium

Illustration by Ajay Mohanty

SI Reporter Mumbai
Shares of Eris Lifesciences have surged 6 per cent to Rs 437 in early morning trade on BSE on Monday after nearly 3 per cent of total equity of pharmaceutical company changed hands via block deals.

Around 3.82 million equity shares representing 2.78 per cent of total equity of Eris Lifesciences have changed hands on the BSE, the exchange data shows. Names of the buyers and sellers could not be ascertained immediately.

Earlier, on November 15, 2019, the foreign institutional investor, Nomura Singapore had purchased 950,000 equity shares or 0.69 per cent stake in the company at Rs

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in